189 related articles for article (PubMed ID: 308530)
41. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.
Hall WW; Lamb RA; Choppin PW
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2047-51. PubMed ID: 287042
[TBL] [Abstract][Full Text] [Related]
42. Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: a study of idiotypic determinants.
Ebers GC; Zabriskie JB; Kunkel HG
Clin Exp Immunol; 1979 Jan; 35(1):67-75. PubMed ID: 85508
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of measles virus-specific IgM antibodies and IgM-class rheumatoid factor in relation to clinical onset of subacute sclerosing panencephalitis.
Ziola B; Halonen P; Enders G
J Med Virol; 1986 Jan; 18(1):51-9. PubMed ID: 3944591
[TBL] [Abstract][Full Text] [Related]
44. Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis.
Dhib-Jalbut S; McFarland HF; Mingioli ES; Sever JL; McFarlin DE
J Virol; 1988 Jul; 62(7):2483-9. PubMed ID: 3373575
[TBL] [Abstract][Full Text] [Related]
45. Detection of IgG antibody to measles virus by radioimmunoassay technique.
Sakata H; Yamanouchi K; Machida K; Matsuzaki F; Shishido A; Iwashita H; Kuroiwa Y
Jpn J Med Sci Biol; 1979 Apr; 32(2):67-76. PubMed ID: 541873
[TBL] [Abstract][Full Text] [Related]
46. Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system.
Mathiesen T; von Holst H; Fredrikson S; Wirsén G; Hederstedt B; Norrby E; Sundqvist VA; Wahren B
J Neurol; 1989 May; 236(4):238-42. PubMed ID: 2760636
[TBL] [Abstract][Full Text] [Related]
47. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis.
Panitch HS; Hooper CJ; Johnson KP
Arch Neurol; 1980 Apr; 37(4):206-9. PubMed ID: 6153890
[TBL] [Abstract][Full Text] [Related]
48. Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system.
Vandvik B; Degré M
J Neurol Sci; 1975 Feb; 24(2):201-19. PubMed ID: 1113135
[TBL] [Abstract][Full Text] [Related]
49. Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles.
Hankins RW; Black FL
J Clin Microbiol; 1986 Sep; 24(3):324-9. PubMed ID: 3531224
[TBL] [Abstract][Full Text] [Related]
50. Different virus antibodies in serum and cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis.
Abdelnoor AM; Dhib-Jalbut SS; Haddad FS
J Neuroimmunol; 1982 Jan; 2(1):27-34. PubMed ID: 6296199
[TBL] [Abstract][Full Text] [Related]
51. Measles virus polypeptide-specific antibody profile in multiple sclerosis.
Dhib-Jalbut S; Lewis K; Bradburn E; McFarlin DE; McFarland HF
Neurology; 1990 Mar; 40(3 Pt 1):430-5. PubMed ID: 2314583
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of antibodies to a human papova virus (BK virus) in subacute sclerosing panencephalitis and multiple sclerosis patients.
Meurman OH; Mäntyjärvi RA; Salmi AA; Panelius M
Z Neurol; 1972; 203(2):191-4. PubMed ID: 4119029
[No Abstract] [Full Text] [Related]
53. [Changes in the level of humoral response for measles virus in patients with subacute sclerotic panencephalitis during 1984-1989].
Gut W
Med Dosw Mikrobiol; 1992; 44(3-4):173-85. PubMed ID: 1305922
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic reference value of antibody levels measured using enzyme immunoassay for subacute sclerosing panencephalitis.
Kume Y; Hashimoto K; Iida K; Maeda H; Miyazaki K; Ono T; Chishiki M; Suzuki Y; Go H; Suyama K; Hosoya M
Microbiol Immunol; 2022 Sep; 66(9):418-425. PubMed ID: 35766430
[TBL] [Abstract][Full Text] [Related]
55. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Patrick BA; Sobczyk W; Wisniewski HM
J Neurol Sci; 1992 May; 109(1):64-8. PubMed ID: 1381411
[TBL] [Abstract][Full Text] [Related]
56. Radioimmunoassay of measles virus antibodies in SSPE.
Jankowski MA; Gut W; Kańtoch M
Acta Virol; 1982 Dec; 26(6):481-7. PubMed ID: 6132542
[TBL] [Abstract][Full Text] [Related]
57. A solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus.
Arstila P; Vuorimaa T; Kalimo K; Halonen P; Viljanen M; Granfors K; Toivanen P
J Gen Virol; 1977 Jan; 34(1):167-76. PubMed ID: 833576
[TBL] [Abstract][Full Text] [Related]
58. Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE.
Trudgett A; Bellini WJ; Mingioli ES; McFarlin DE
Clin Exp Immunol; 1980 Mar; 39(3):652-6. PubMed ID: 6991172
[TBL] [Abstract][Full Text] [Related]
59. Subacute sclerosing panencephalitis antibodies against measles virus polypeptides.
Karcher D; Thormar H; Lowenthal A; Noppe M
J Neurol; 1982; 227(1):29-34. PubMed ID: 6176691
[TBL] [Abstract][Full Text] [Related]
60. [Measles antibodies in serum and CSF].
Castaigne P; Cathala F; Chateau AF; Schuller E; Collomb P; Baylet R; Girard P; Dumas N
Nouv Presse Med; 1973 Apr; 2(14):895-9. PubMed ID: 4574820
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
